MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Systematic Review of Non-pharmacological Interventions for Respiratory Health in Parkinson’s Disease (PD)

    L. Mcmahon, O. Lennon, C. Blake (Dublin, Ireland)

    Objective: This study systematically reviews randomized controlled trials (RCTs) and control trials of non-pharmacological interventions currently used to improve respiratory function/metrics for people with PD.…
  • 2019 International Congress

    Intestinal nerve damage and gut dysfunction in mouse models of Parkinson’s Disease

    R. Mcquade, R. Constable, E. Lei, M. Di Natale, J. Berger, J. Kauhausen, C. Parish, D. Finkelstein, J. Furness, S. Diwakarla (Melbourne, Australia)

    Objective: This work aims to investigate gut dysfunction and enteric neuropathy in several mouse models of PD to provide insight into enteric nervous system (ENS)…
  • 2019 International Congress

    A Study of Social Cognition in Parkinson’s Disease

    S. Meenakshisundaram, LN. Ranganathan (Chennai, India)

    Objective: To study the social cognition in patients with PD and compare it with normal controls Background: Patients with PD have difficulty expressing emotion which…
  • 2019 International Congress

    Evaluation of the Zeez Sleep Pebble for Sleep Disturbance in Parkinson’s Disease

    S. Milne, S. Cummins, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the effect of the Zeez Sleep Pebble© on sleep disturbance in Parkinson’s disease. Background: Sleep disturbance is common in Parkinson’s disease (PD)…
  • 2019 International Congress

    Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology

    D. Mohanty, A. Lingaiah, J. Doak, A. Jacob, R. Castellanos, V. Holiday, A. Espay, K. Lafaver (Louisville, KY, USA)

    Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…
  • 2019 International Congress

    How Parkinson’s Disease Affects Value-Based Decisions

    L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

    Objective: Parkinson’s Disease (PD) is a degenerative motor disease that causes subtle deficits in decision-making as a result of striatal dysfunction due to dopamine depletion.…
  • 2019 International Congress

    Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

    B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)

    Objective: To describe and correlate the apathy and cognitive profile of patients with Parkinson’s disease (PD). Background: Prevalence of apathy in PD is highly variable…
  • 2019 International Congress

    Functional Bowel Symptoms in Parkinson´s Disease

    K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, J. Joutsa, R. Levo, E. Pekkonen, V. Kaasinen, F. Scheperjans (Hus, Finland)

    Objective: We assessed the prevalence of functional bowel disorders in patients with Parkinson´s disease (PD) using Rome III criteria. Background: A significant fraction of PD…
  • 2019 International Congress

    The effect of istradefylline on mood disorders in Parkinson’s disease

    H. Nagayama, O. Kano, H. Murakami, M. Hamada, R. Sengoku, Y. Shim, T. Toda (Tokyo, Japan)

    Objective: The effectiveness of istradefylline for treatment of mood disorders in patients with Parkinson's disease (PD) was examined in an open-label trial. Background: Depression is…
  • 2019 International Congress

    Fatigue in Parkinson’s disease and its relation with disease duration and treatment

    D. Nassif, J. Pereira (Rio de Janeiro, Brazil)

    Objective: Identify the presence of fatigue in a population of PD patients, establishing its association with disease duration and treatment. Background: Fatigue is one of…
  • « Previous Page
  • 1
  • …
  • 1132
  • 1133
  • 1134
  • 1135
  • 1136
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley